Two of the biggest insider stories this week sit at opposite ends of the conviction spectrum.
At ELV, CEO Gail Boudreaux filed on July 17 that she bought over $1M worth of shares in a single day. Board chairman Ramiro Peru bought another $366,000 on the same date. Together, the pair spent roughly $1.37M. The open-market purchases come as Elevance Health trades well off recent highs, and a CEO buying alongside the chairman is a rare, coordinated signal of confidence.
At TTAN, the story is the reverse. Bessemer Venture Partners has filed 15 separate sale transactions since late June, totaling over $117M in combined proceeds. The VC firm, a 10% owner with a board seat, has been selling almost every trading day. A director and the Chief Accounting Officer also filed sales. The wave of supply from early backers is one of the clearest post-IPO exit patterns seen this month.
At MS, CFO Sharon Yeshaya filed $3.5M in sales on July 16–17. Division head Michael Pizzi sold a further $5.2M over the same two days. The trades follow [MS] shares pushing toward multi-year highs.
CRWD director Denis O'Leary filed a $2.7M sale on July 15, at prices around $188.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
